ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 917

$571K Total Retail Price of All Prescriptions

Rank: 83 out of 917

431 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,051 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 577 473 1 1
AMLODIPINE BESYLATE 377 301 2 5
SIMVASTATIN 325 298 3 2
OMEPRAZOLE 316 249 4 4
HYDROCODONE-ACETAMINOPHEN 306 274 S3 5 6
WARFARIN SODIUM 285 277 6 10
PRAVASTATIN SODIUM 278 181 7 20
LEVOTHYROXINE SODIUM 274 199 8 3
HYDROCHLOROTHIAZIDE 272 223 9 9
METFORMIN HCL 267 185 10 8
FUROSEMIDE 222 206 11 7
GABAPENTIN 205 153 12 17
METOPROLOL SUCCINATE 196 183 13 18
FLUTICASONE PROPIONATE 191 129 14 26
CITALOPRAM HBR 182 167 15 15
ATENOLOL 166 146 16 12
ALLOPURINOL 148 130 17 31
TRAMADOL HCL 142 111 18 28
TAMSULOSIN HCL 138 118 19 25
POTASSIUM CHLORIDE 136 110 20 16
TRAZODONE HCL 124 61 21 22
PREDNISONE 122 90 22 34
ATORVASTATIN CALCIUM 122 91 22 14
METOPROLOL TARTRATE 114 97 24 11
LOSARTAN POTASSIUM 110 92 25 13
ZOLPIDEM TARTRATE 109 84 26 21
MIRTAZAPINE 108 96 27 39
GLIPIZIDE 106 80 28 40
NIFEDIPINE ER 103 103 29 139
LANTUS SOLOSTAR 98 60 30 63
DIGOXIN 93 92 31 41
LOVASTATIN 86 77 32 19
NOVOLOG FLEXPEN 82 46 33 132
OXYCODONE HCL 81 72 S2 34 27
MORPHINE SULFATE ER 79 53 S2 35 48
SERTRALINE HCL 75 27 36 24
NAPROXEN 72 40 37 107
BUPROPION HCL SR 67 23 38 101
CHLORTHALIDONE 64 59 39 113
FLUOXETINE HCL 63 20 40 38
AMITRIPTYLINE HCL 61 36 R 41 67
CARVEDILOL 60 36 42 33
RANITIDINE HCL 59 17 43 29
ALENDRONATE SODIUM 58 41 44 23
OXYBUTYNIN CHLORIDE 58 52 44 76
PEN NEEDLE 57 37 46 99
METHOTREXATE 54 39 47 183
HUMALOG 54 32 47 151
IBUPROFEN 52 20 49 97
TRIAMCINOLONE ACETONIDE 52 35 49 96
GEMFIBROZIL 50 28 51 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.